Structurally, AHK-Cu pairs a short tripeptide carrier with a bound copper ion, a combination researchers use to study copper transport, extracellular matrix signaling, and follicle-focused cell behavior
Patients on GLP-1 programs such as semaglutide or tirzepatide sometimes use it as a complementary metabolic support injection
Treatment duration typically follows 6-12 week cycles with 4-8 week breaks, though no evidence supports this pattern
This 16-amino-acid sequence was designed to capture the fat metabolizing properties of growth hormone without triggering the broader hormonal effects that make full-length GH problematic for many users
Taylor Kantor, his brother Anthony, and Anthonys wife Kelly to reimagine care for cardiometabolic health
See related preclinical literature on PubMed